Skip to Main Content

CAR-T

Animal-origin-free proteins for every step of CAR-T manufacturing.

From leukapheresis to cryopreservation, recombinant albumin, transferrin, IL-2 and insulin-transferrin supplements replace serum and plasma-derived proteins, lowering variability across autologous and allogeneic runs.

Where InVitria proteins fit

CAR-T is a chain of sensitive, sequential steps on scarce cells, where variability compounds at every transfer. Animal-origin-free recombinant proteins lower that risk step by step.

Where our products fit

The CAR-T workflow, step by step.

Eight workflow steps in manufacturing order. Select any step to see the recommended products grouped by function, and why each one is used.

Leukapheresis

Collect high-quality mononuclear cells as starting material, and stabilize the product for hold and transport with defined, animal-origin-free albumin.

Overview

Leukapheresis is the first step in CAR-T manufacturing. Blood is drawn through an apheresis machine that collects the mononuclear cell fraction, including the T cells that become the therapy, and returns the rest to the patient. For autologous therapy the cells come from the patient; for allogeneic, from a donor. This collected material is the starting material for the entire process.

The machine does not distinguish between cell subsets, so the product is a heterogeneous mix. T cell selection happens later, at isolation. Longer time between collection and processing is associated with viability loss, which makes the hold-and-transport window worth protecting. Adding a defined, animal-origin-free albumin after collection supports cell health by buffering cells against handling stress.

Functions

Starting Material Stabilization

After collection, the apheresis product is held and shipped before processing begins, sometimes over significant distances and time. Cells are exposed to handling, temperature shifts, and surface contact during this window, and longer time to processing is associated with viability loss. A stabilizing protein in the collected material supports cell health through hold and transport, before isolation and culture begin

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived (HSA) serum albumin used to stabilize collected cellular material.

Cell Isolation & Washing

Wash and enrich T cells from the apheresis product, with defined, animal-origin-free albumin supporting cell health through selection.

Overview

Cell isolation and washing prepares the starting material for manufacturing. The apheresis product is washed to remove anticoagulant, plasma, platelets, and debris and to reduce volume. Target T cells are then enriched from the heterogeneous mononuclear mix, usually by immunomagnetic selection: cells are labeled with antibody-conjugated magnetic beads and separated on a column.

Selection and wash buffers are typically PBS with EDTA, supplemented with albumin. The albumin is supplied by the processing site, not built into the buffer. It supports cells through bead labeling and column separation, limiting cell loss and protecting viability during handling.

A defined, animal-origin-free recombinant albumin, used in place of human serum albumin, keeps this step consistent and free of human- and animal-derived material before activation and culture begin.

Functions

Cell Protection & Stabilization

During wash and magnetic selection, cells undergo buffer exchange, bead labeling, and column passage. This handling can stress cells and cause loss to tubing, column, and container surfaces. A protein in the buffer buffers cells against that stress and limits adsorption, supporting recovery and viability before the cells move into activation and culture.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Human serum albumin (HSA) supplemented into selection and wash buffers.

T Cell Activation

Activate isolated T cells and support their entry into proliferation with defined, animal-origin-free components, priming them for gene transfer.

Overview

T cell activation prepares isolated T cells for genetic modification. Cells are stimulated, most often with anti-CD3/CD28 antibody-coated beads, though soluble reagents and artificial antigen-presenting cells are also used, typically with cytokines present over one to three days. This moves the cells out of quiescence and into the cell cycle, where they become receptive to gene transfer.

As cells activate, demand rises across several needs at once: cytokine signaling to support survival and proliferation, iron to fuel DNA synthesis as the transferrin receptor is upregulated, carrier protein to buffer handling stress, and metabolic support. These are usually met in a defined culture medium.

Meeting these needs with defined, animal-origin-free components, rather than serum, supports consistent activation and reduces variability before transduction begins.

Functions

Cytokine Signaling

Once T cells are activated through CD3/CD28 engagement, cytokine signaling supports their survival and entry into proliferation. IL-2 sustains the activated state and drives the first rounds of division before expansion scales the population up. Consistent cytokine input during activation supports a uniform starting point for the rest of the process.

Recommendation
OptiLeukin™ 2

Recombinant human interleukin-2 from a non-bacterial expression system for T-cell, Treg, TIL, NK, and γδ T-cell expansion, from research to cGMP manufacturing.

Commonly replaces
Mammalian-cell-derived IL-2; E. coli-derived recombinant IL-2 products.

Iron Transport

Activation drives T cells into the cell cycle, and iron demand rises sharply to support DNA synthesis and metabolism. The transferrin receptor is upregulated as a hallmark of activation, so iron delivery becomes rate-relevant at this step. Transferrin binds ferric iron and delivers it through that receptor in a controlled, protein-bound form, rather than as free iron, which can add oxidative stress.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Plasma- or blood-derived transferrin, and free iron supplementation.

Carrier & Protection

During bead-based activation and early culture, T cells are exposed to handling, surface contact, and the metabolic stress of exiting quiescence. Albumin is the primary protein that transports fatty acids and metal ions, contributes antioxidant capacity, and buffers cells against shear and adsorption to surfaces, supporting viability through the activation window.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived (HSA) or bovine (BSA) serum albumin, and serum used as a stabilizing protein.

Activation Environment Support

Activating T cells need iron, metabolic cofactors, and carrier protein together to move cleanly into proliferation in a defined medium. Meeting these needs through defined components, rather than serum, supports consistent activation and reduces the lot-to-lot variability serum introduces during a step that sets the starting point for the whole process.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
Human AB serum, fetal bovine serum, and other undefined serum supplementation.

Genetic Modification

Protect cell health and maintain defined, animal-origin-free conditions through viral exposure and handling during gene transfer.

Overview

Genetic modification is the step where activated T cells are engineered to express the chimeric antigen receptor (CAR). Gene transfer is most often performed by viral transduction with a lentiviral or retroviral vector, though non-viral methods such as transposon systems and electroporation are also used. Transduction performance can influence engineering efficiency, cell viability, expansion potential, and final product consistency.

During gene transfer, cells may be exposed to viral particles, media changes, and handling stress that affect cell health. Viral vectors themselves can be sensitive to surface adsorption and processing variability.

A controlled, animal-origin-free transduction strategy helps protect cell health, support efficient gene delivery, and maintain consistent conditions through one of the most sensitive steps in CAR-T manufacturing.

Gene Therapy & Vector Production > Lentiviral Vector (LVV) Gene Therapy

Functions

Cell Protection & Stabilization

Albumin is the primary protein that buffers cells against shear, limits oxidative stress, and reduces adsorption of cells and proteins to culture surfaces. Stabilizing the environment this way protects membrane integrity through transduction and supports consistent recovery into expansion.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived (HSA) or bovine (BSA) serum albumin, and serum used as a stabilizing protein.

Iron Transport

Activated T cells require iron for metabolism and to stay proliferation-ready through gene transfer. Transferrin binds ferric iron and delivers it through the transferrin receptor in a controlled, protein-bound form, rather than as free iron, which can contribute to oxidative stress during a sensitive step.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Plasma- or blood-derived transferrin, and free iron supplementation.

Pre & Post Transduction Environment Support

Carrier proteins, iron, and cofactors for oxidative balance keep T cells viable through transduction and ready to recover into expansion. Meeting these needs through defined components, rather than serum, supports cell health and consistent conditions across runs.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
FBS, human serum, or undefined serum supplementation

T Cell Expansion

Maintain T cell proliferation, viability, and functional consistency while reducing undefined and animal-origin components in expansion media.

Overview

Cell expansion increases the number of modified T cells to reach the target therapeutic dose. Cells must proliferate efficiently while maintaining viability, phenotype, and the functional characteristics needed for the final CAR-T product.

Expansion outcomes depend on nutrient availability, cytokine stability, media composition, oxygen transfer, culture format, cell density, and process timing. Undefined or animal-origin components can introduce lot-to-lot variability and make performance harder to compare across runs.

A defined, animal-origin-free expansion strategy supports scalable manufacturing, consistent cell growth, and greater confidence in final product quality.

Functions

Cytokine Signaling

Cytokine signaling sustains proliferation and survival of activated T cells during expansion. IL-2 is a primary growth signal driving clonal expansion to the target dose.

Recommendation
OptiLeukin™ 2

Recombinant human interleukin-2 from a non-bacterial expression system for T-cell, Treg, TIL, NK, and γδ T-cell expansion, from research to cGMP manufacturing.

Commonly replaces
Mammalian-cell-derived IL-2; E. coli-derived recombinant IL-2 products

Iron Transport

Proliferating T cells require iron for DNA synthesis and metabolic activity during expansion. Transferrin is the physiological carrier that binds ferric iron and delivers it through the transferrin receptor, which is upregulated on actively dividing cells. A defined iron-delivery mechanism supports consistent proliferation and viability and avoids the variability of undefined iron sources.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Human plasma- or blood-derived transferrin, and serum used as an iron source.

Carrier & Protection

Albumin is the primary protein carrier in culture. It binds and transports fatty acids, lipids, metal ions, and other small molecules to cells, contributes antioxidant capacity, and buffers cells against shear and handling stress. During expansion, where cells proliferate under bioreactor and processing conditions, this carrier and protective role supports viability and consistent growth.

Recommendation
Cellastim® S

Cell culture recombinant albumin to enhance proliferation in serum free and chemically defined cell culture. Lyophilized.

Commonly replaces
Human plasma-derived serum albumin (HSA) and bovine serum albumin (BSA)

Expansion Environment Support

Expanding T cells depend on a stable culture environment to proliferate consistently while maintaining viability and phenotype. They need carrier proteins to transport lipids and buffer stress, iron for metabolism and DNA synthesis, and metabolic cofactors that support nutrient utilization and oxidative balance. Meeting these needs through defined components, rather than serum, supports consistent growth and reduces variability across runs.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
FBS, human serum, or undefined serum supplementation

Harvest & Concentration

Wash and concentrate the engineered cells for formulation, with defined, animal-origin-free albumin protecting them through processing.

Overview

Harvest and concentration prepares the expanded cells for final formulation. The engineered T cells are collected from culture, washed to remove spent media and process residuals, and concentrated through volume reduction, usually by counterflow centrifugation or filtration. The goal is a clean, concentrated cell suspension ready for fill.

Wash and concentration buffers are saline or PBS supplemented with albumin. The albumin protects cells against the shear of centrifugation or filtration and limits loss to surfaces during processing. Because the cells are washed into this buffer as they approach fill, residual process proteins matter here: bovine albumin, a common additive, is a tracked impurity in the final product.

A defined, animal-origin-free recombinant albumin protects cells through concentration while avoiding the animal-derived residuals that carry toward the drug product.

Functions

Cell Protection & Stabilization

During harvest and concentration, cells are washed and volume-reduced by counterflow centrifugation or filtration, which subjects them to shear and surface contact. Albumin in the buffer buffers cells against that mechanical stress, limits adhesion and loss to surfaces, and supports viability and recovery as the product is concentrated for formulation.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Human serum albumin (HSA) or bovine serum albumin (BSA) supplemented into wash and concentration buffers.

Final Formulation & Fill Prep

Formulate the engineered cells into their final matrix with defined, animal-origin-free recombinant albumin, a drug-product excipient that stabilizes the product for fill and storage.

Overview

Final formulation and fill prep brings the product to its finished form. The concentrated cells are suspended in the matrix they will be stored and administered in, then filled into the primary container, a cryobag or vial. A common formulation is an electrolyte solution such as Plasma-Lyte A with a cryoprotectant and albumin.

Albumin is a standard excipient in these matrices. It stabilizes the cells and protects them through formulation and into freezing. Because this is the drug product, excipient safety matters: plasma-derived albumin carries adventitious-agent risk that a recombinant source removes.

A defined, animal-origin-free recombinant albumin stabilizes the formulated product while keeping the final matrix free of human- and animal-derived material as it goes to fill.

Functions

Formulation Stabilization

In final formulation, the concentrated cells are suspended in the matrix they will be stored and administered in, commonly an electrolyte solution with a cryoprotectant. Albumin is a standard excipient in this matrix. It stabilizes cells, buffers them against the osmotic and handling stress of formulation and the hold before freezing, and limits adsorption to the container. As a drug-product excipient, its quality and safety profile carry into the final product.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived human serum albumin (HSA) used as a formulation excipient.

Cryopreservation

Freeze and store the formulated product, with defined, animal-origin-free albumin supporting cell stability through freeze-thaw and recovery.

Overview

Cryopreservation freezes and stores the finished product. The formulated cells are cooled in a controlled-rate freezer and held in cryogenic storage, typically below -120°C in the vapor phase of liquid nitrogen, then thawed at the point of care before infusion. Freezing decouples manufacturing from the treatment schedule and allows shipment and storage of doses.

Freeze-thaw exposes cells to ice formation and osmotic stress. Cryopreservation matrices pair a penetrating cryoprotectant such as DMSO with a protein stabilizer. Albumin is that stabilizer: it buffers cell membranes through freezing and supports viability and recovery on thaw.

A defined, animal-origin-free recombinant albumin supports cryostability while keeping the frozen drug product free of human- and animal-derived material.

Functions

Freeze-Thaw Stabilization

Cryopreservation exposes cells to ice crystal formation, osmotic shifts, and membrane stress during freezing and thawing. Cryopreservation matrices pair a penetrating cryoprotectant such as DMSO with a protein stabilizer. Albumin acts as that stabilizer, a non-penetrating component that buffers membranes against osmotic and oxidative stress and supports cell viability and recovery after thaw.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived human serum albumin (HSA) used as a cryopreservation stabilizer.